Continuous hyperthermic peritoneal perfusion with cisplatin in mice with peritoneal dissemination of B16 melanoma

Toshiro Okuyama, Kazuya Endo, Yoshihiko Maehara, Hideo Baba, Tatsuo Oshiro, Yosuke Adachi, Keizo Sugimachi

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

We designed a model of peritoneal dissemination of gastric cancer in mice. B16 melanoma cells were injected into the peritoneal cavity of C57 BL mice, the object being to search for an effective treatment for peritoneal dissemination, using hyperthermia combined with cisplatin. Following the intraperitoneal administration of tumor cells, each mouse was subjected to continuous hyperthermic peritoneal perfusion (CHPP) using the peritoneal cavity expander (PCE), with or without cisplatin in the perfusate under conditions of laparotomy. Effects of the therapy were evaluated, based on comparison of survival time between the control and treated groups. There was no prolongation of mean survival periods for the groups given CHPP, with or without cisplatin, compared to findings in the no treatment control group. Optimal timing and doses of hyperthermia and cisplatin, or adding biochemical modulators to enhance the effects of cisplatin, will need to be determined to increase the efficacy of CHPP, with or without the concomitant administration of cisplatin. © 1994 Wiley‐Liss, Inc.

Original languageEnglish
Pages (from-to)145-149
Number of pages5
JournalSeminars in Surgical Oncology
Volume10
Issue number2
DOIs
Publication statusPublished - Jan 1 1994

Fingerprint

Experimental Melanomas
Cisplatin
Perfusion
Peritoneal Cavity
Fever
Control Groups
Laparotomy
Stomach Neoplasms
Neoplasms

All Science Journal Classification (ASJC) codes

  • Surgery
  • Oncology

Cite this

Continuous hyperthermic peritoneal perfusion with cisplatin in mice with peritoneal dissemination of B16 melanoma. / Okuyama, Toshiro; Endo, Kazuya; Maehara, Yoshihiko; Baba, Hideo; Oshiro, Tatsuo; Adachi, Yosuke; Sugimachi, Keizo.

In: Seminars in Surgical Oncology, Vol. 10, No. 2, 01.01.1994, p. 145-149.

Research output: Contribution to journalArticle

Okuyama, Toshiro ; Endo, Kazuya ; Maehara, Yoshihiko ; Baba, Hideo ; Oshiro, Tatsuo ; Adachi, Yosuke ; Sugimachi, Keizo. / Continuous hyperthermic peritoneal perfusion with cisplatin in mice with peritoneal dissemination of B16 melanoma. In: Seminars in Surgical Oncology. 1994 ; Vol. 10, No. 2. pp. 145-149.
@article{e518984f10b94886900ec31b1b5ca9b0,
title = "Continuous hyperthermic peritoneal perfusion with cisplatin in mice with peritoneal dissemination of B16 melanoma",
abstract = "We designed a model of peritoneal dissemination of gastric cancer in mice. B16 melanoma cells were injected into the peritoneal cavity of C57 BL mice, the object being to search for an effective treatment for peritoneal dissemination, using hyperthermia combined with cisplatin. Following the intraperitoneal administration of tumor cells, each mouse was subjected to continuous hyperthermic peritoneal perfusion (CHPP) using the peritoneal cavity expander (PCE), with or without cisplatin in the perfusate under conditions of laparotomy. Effects of the therapy were evaluated, based on comparison of survival time between the control and treated groups. There was no prolongation of mean survival periods for the groups given CHPP, with or without cisplatin, compared to findings in the no treatment control group. Optimal timing and doses of hyperthermia and cisplatin, or adding biochemical modulators to enhance the effects of cisplatin, will need to be determined to increase the efficacy of CHPP, with or without the concomitant administration of cisplatin. {\circledC} 1994 Wiley‐Liss, Inc.",
author = "Toshiro Okuyama and Kazuya Endo and Yoshihiko Maehara and Hideo Baba and Tatsuo Oshiro and Yosuke Adachi and Keizo Sugimachi",
year = "1994",
month = "1",
day = "1",
doi = "10.1002/ssu.2980100217",
language = "English",
volume = "10",
pages = "145--149",
journal = "Journal of Surgical Oncology",
issn = "0022-4790",
publisher = "Wiley-Liss Inc.",
number = "2",

}

TY - JOUR

T1 - Continuous hyperthermic peritoneal perfusion with cisplatin in mice with peritoneal dissemination of B16 melanoma

AU - Okuyama, Toshiro

AU - Endo, Kazuya

AU - Maehara, Yoshihiko

AU - Baba, Hideo

AU - Oshiro, Tatsuo

AU - Adachi, Yosuke

AU - Sugimachi, Keizo

PY - 1994/1/1

Y1 - 1994/1/1

N2 - We designed a model of peritoneal dissemination of gastric cancer in mice. B16 melanoma cells were injected into the peritoneal cavity of C57 BL mice, the object being to search for an effective treatment for peritoneal dissemination, using hyperthermia combined with cisplatin. Following the intraperitoneal administration of tumor cells, each mouse was subjected to continuous hyperthermic peritoneal perfusion (CHPP) using the peritoneal cavity expander (PCE), with or without cisplatin in the perfusate under conditions of laparotomy. Effects of the therapy were evaluated, based on comparison of survival time between the control and treated groups. There was no prolongation of mean survival periods for the groups given CHPP, with or without cisplatin, compared to findings in the no treatment control group. Optimal timing and doses of hyperthermia and cisplatin, or adding biochemical modulators to enhance the effects of cisplatin, will need to be determined to increase the efficacy of CHPP, with or without the concomitant administration of cisplatin. © 1994 Wiley‐Liss, Inc.

AB - We designed a model of peritoneal dissemination of gastric cancer in mice. B16 melanoma cells were injected into the peritoneal cavity of C57 BL mice, the object being to search for an effective treatment for peritoneal dissemination, using hyperthermia combined with cisplatin. Following the intraperitoneal administration of tumor cells, each mouse was subjected to continuous hyperthermic peritoneal perfusion (CHPP) using the peritoneal cavity expander (PCE), with or without cisplatin in the perfusate under conditions of laparotomy. Effects of the therapy were evaluated, based on comparison of survival time between the control and treated groups. There was no prolongation of mean survival periods for the groups given CHPP, with or without cisplatin, compared to findings in the no treatment control group. Optimal timing and doses of hyperthermia and cisplatin, or adding biochemical modulators to enhance the effects of cisplatin, will need to be determined to increase the efficacy of CHPP, with or without the concomitant administration of cisplatin. © 1994 Wiley‐Liss, Inc.

UR - http://www.scopus.com/inward/record.url?scp=0028359430&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028359430&partnerID=8YFLogxK

U2 - 10.1002/ssu.2980100217

DO - 10.1002/ssu.2980100217

M3 - Article

VL - 10

SP - 145

EP - 149

JO - Journal of Surgical Oncology

JF - Journal of Surgical Oncology

SN - 0022-4790

IS - 2

ER -